MEDRX aims to contribute to the improvement of global health and QOL by developing groundbreaking new medication.
fully utilizing our technological resources on drug formulation commencing with the transdermal absorption technology.
R&D MEDRx research and development
We continue to research and develop new drugs for patients, such as ILTS® technology, NCTS® technology, and microneedles.
-
- MEDRx's proprietary transdermal formulation technology ILTS®
- This is a technology that dramatically improves transdermal permeability through transdermal absorption formulation technology that utilizes ionic liquids.
-
- NCTS®
- This is a transdermal drug formulation technology that utilizes "nanocolloids" in a solution state with ultra-fine particles of 100 nano-size.
-
COMPANY
MEDRx is a pharmaceutical formulation development company that aims to improve people's health and quality of life by developing new dosage forms of medicines, such as those that prevent patients from forgetting to take medicines or that are difficult to administer orally.
